Uae Medical Device Registration Service
A UAE medical device registration service should deliver a complete, traceable filing—not merely a list of certificates. The federal marketing-authorisation application is handled by the Emirates Drug Establishment (EDE). Before uploading, establish whether this exact product requires EDE authorisation, who can file, and which manufacturing site and models the application covers.
This is the execution workflow for medical devices generally. An overseas CE certificate or US FDA decision can support evidence but is not itself a UAE approval. Classification decisions and exceptions must be confirmed for the actual product; an import permit is a separate step where applicable.
Four go/no-go checks before preparing the submission
Treat these as filing gates, not assumptions based on the manufacturer's overseas sales history. EDE also lists local pharmaceutical manufacturers in the service target audience; their precise applicant-account eligibility must be checked with EDE, rather than presumed excluded. EDE allows companies and individuals to request a product classification; this does not make them eligible applicants for the separate medical-device marketing-authorisation filing.
EDE permits MAH registration documents to accompany the manufacturing-site registration application. That is not permission to file the device application before the required holder and site registrations have been completed.
| Pre-filing finding | Consequence | Next controlled action |
|---|---|---|
| Regulatory category or authorisation requirement uncertain | Selecting an inapplicable EDE service can lead to rework or rejection | Collect intended use, mode of action, catalogue, images and label; seek EDE product classification where needed. For a classification request, also check EDE’s separate requirements for applicant ID, inner/outer labels, a leaflet in English or Arabic and available country-of-origin status evidence. |
| Marketing-authorisation holder or manufacturing site not yet registered with EDE | The product file is not filing-ready | Confirm registration status; complete relevant holder/site registration steps first. |
| UAE submission account not yet verified for its entity type (medical warehouse, marketing office or local pharmaceutical manufacturer) | Filing authority and, where relevant, the product-agency chain remain unresolved | Check the EDE licence for a warehouse/marketing office; confirm a local pharmaceutical manufacturer’s accepted portal role with EDE. Verify the agency mandate where applicable. |
| Category, holder/site, local applicant and model scope are verified | Proceed to controlled dossier assembly | Freeze names, model list, device claims and evidence versions before upload. |
Who supplies, files and answers for the dossier
The legal roles must be verified against EDE records and the actual contracts. A consultant preparing a file is not automatically the licensed applicant or an authorised importer.
| Party | Filing responsibility | Evidence to confirm |
|---|---|---|
| Manufacturer / marketing-authorisation holder | Approves intended use, model scope, technical claims, declarations, conformity evidence and regulatory responses. | Signed application inputs, current approvals, device information and final review sign-off. |
| EDE-eligible UAE submitting entity: usually a licensed medical warehouse or marketing office; local pharmaceutical manufacturers require a role check | Submits through an authorised EDE account, pays fees and responds to comments; verifies its permitted filing role and any agency mandate. | Valid EDE licence or other EDE-confirmed filing eligibility, account access and product agency agreement where applicable. |
| Registration support team | Builds the evidence index, checks consistency, logs queries and prepares the final handover; does not replace a licence or authority decision. | Dossier map, version log, deficiency tracker and copies of submitted/approved records. |
Submission-ready evidence register: what goes into the file
EDE lists the following materials on its medical-device service page. Applicability of samples, analysis and special evidence depends on the device; do not treat every item as a universal test requirement.
| Dossier group | Evidence to collect or validate | Typical acceptance check |
|---|---|---|
| Applicant and establishment | Signed/stamped application; EDE factory registration; holder and local applicant eligibility; manufacturer–agent contract. | Same legal entities, site address and authorised product scope throughout. |
| Origin and prior authorisations | Valid free-sale/registration certificate from country of origin certified by UAE Embassy; relevant EC/CE, US 510(k), PMA or other conformity/market authorisation evidence, as applicable. | Current, legible documents linked to the actual product/models; foreign approval is not automatic UAE recognition. |
| Device identification | Description, intended use, models, sizes, accessories, product pictures, packaging, brochures, instructions, warnings, precautions and contraindications. | Catalogue, certificates, label and application describe the same device and intended use. |
| Conformity and surveillance | Manufacturer declaration of conformity and information addressing post-marketing monitoring requirements. | Declarations match the device identity and a responsible party can maintain the post-market record. |
| Higher-risk safety evidence | Safety and efficacy data for devices classified by EDE as Class III or IV. | Evidence supports the claimed use and the submitted risk classification. |
| Conditional special material | Sample/certificate of analysis, applicable laboratory information, and animal-origin conformity evidence when relevant. | Request by device type and EDE review, rather than assuming every device needs each test. |
EDE portal filing and authority-query control
The official service describes UAE PASS access, online form, attachments, electronic fees and issuance after regulatory review. The following handoff controls are an operational filing method, not separate statutory stages.
- Confirm account eligibility, EDE holder/site records, product route and the exact models to be covered.
- Build a file index and compare trade names, site addresses, risk category, indications and model codes across all exhibits.
- Have the holder and UAE applicant sign off on the final dossier; submit through the EDE service using UAE PASS and retain the submission acknowledgement.
- Pay the EDE charges shown in the live application; save receipts and a dated copy of the submitted set.
- Track EDE portal comments. Assign each clarification to a document owner, respond with a versioned exhibit and record the submission date; never assume a query is approval.
- On decision, verify the certificate's holder, manufacturer, product name, model scope and validity against the approved file. Preserve the decision and correspondence for renewal/change control.
Common delays: fix the underlying mismatch, not just the attachment
| Observed deficiency | Why the file stalls | Remedial action |
|---|---|---|
| Agent name or scope differs across application and agency agreement | EDE cannot readily reconcile the filing entity and product mandate | Update the contractual evidence and application consistently before resubmission. |
| Certificate covers a different site, model or intended use | Product identity and supporting authorisation no longer align | Obtain corrected source evidence or narrow the model scope; do not silently substitute a device. |
| Expired, uncertified or unreadable origin/free-sale document | EDE's published documentary requirement is not evidenced | Obtain a current correctly certified source document. |
| Higher-risk claims without corresponding safety/efficacy evidence | A Class III/IV application lacks risk-related support | Prepare traceable clinical/performance evidence and discuss any gaps with EDE before claiming completeness. |
After approval: shipment route, variations and five-year validity
The EDE medical-device service states that its marketing-authorisation certificate is valid for five years from the committee's approval. This is distinct from the service's stated review duration. Its import-permit service separately addresses importing and clearance; for products requiring authorisation it refers to an EDE authorisation and the local agent named in it. Do not release shipments solely because the registration dossier was submitted.
- Check the actual certificate before import: approved models, holder, local agent and validity; then verify the separate import-permit and customs steps applicable to the shipment.
- Route changes in registered product data through the relevant EDE amendment service where applicable; do not assume a revised label, model or manufacturer detail is automatically covered.
- Maintain EDE correspondence, post-market monitoring data and renewal evidence. EDE publishes a dedicated medical-device renewal service; check current requirements and portal wording rather than relying on the original filing alone.
Published EDE service metrics and measurable handover
The EDE medical-device authorisation page currently displays AED 100 as its application fee, AED 5,000 as the device-registration fee, and 45 working days as the service-completion duration. Those are published service figures, not a total project quotation or a guaranteed elapsed timeline. Holder/site registration, legalisation, translation, conditional studies, agency, import permits and professional services may create separate work or cost. Confirm the applicable fees in the live portal.
- A filing-ready intake sheet identifying applicant, holder, site, product category, model scope and open decisions.
- An indexed dossier with source owners, expiry dates and an exceptions/deficiency register.
- Submission evidence, payment receipts, all EDE questions and version-controlled responses.
- The final decision/certificate or refusal, plus a handover calendar for variations, import dependencies and renewal.
What this page does not replace
If the product's regulatory category or approval strategy is unresolved, use the dedicated advisory page. IVD reagents and diagnostics have product-specific evidence questions. Broad UAE market-entry routing is a separate problem; this page concentrates on filing execution after the relevant route has been determined.
Questions at the filing desk
Can we apply with a CE certificate but no UAE-embassy-certified free-sale certificate?
EDE lists a valid country-of-origin free-sale/registration document certified by the UAE Embassy and also lists relevant conformity/foreign authorisation evidence. A CE document should not be treated as a substitute without an EDE determination; close the missing-document point before filing.
The manufacturer is registered but the UAE distributor is not licensed by EDE. Can the consultant file instead?
No. Preparing documents does not by itself entitle a consultant to submit. EDE’s eligibility FAQ specifies an EDE-licensed medical warehouse or marketing office, while its target-audience list also includes local pharmaceutical manufacturers. Check the actual account role directly with EDE; neither an unlicensed distributor nor a consultant should be presumed eligible. Confirm the holder/site records and agency authority before filing.
Does one certificate automatically cover accessories and future models?
Do not assume it does. State the precise types, sizes, models and accessories in the application and reconcile them with the resulting certificate. New or changed scope requires a documented regulatory check and possibly an EDE amendment or new submission.
Does the 45-working-day figure include site registration, legalization and customs?
No such end-to-end guarantee appears on the medical-device service page. It is EDE's published completion duration for that service; prerequisite registration, document preparation, queries and shipment permits must be planned separately.
Can we ship while an EDE query is open?
An open submission or information request is not a marketing authorisation. Check the device's actual regulatory classification and the EDE import-permit conditions; do not infer clearance from a filed application.